Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Urinary nucleic acid oxidation product levels show differential associations with pharmacological treatment in patients with type 2 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{13942fe2f2a34f5c804ff08f346d2a07,
title = "Urinary nucleic acid oxidation product levels show differential associations with pharmacological treatment in patients with type 2 diabetes",
abstract = "The relationship between RNA and DNA oxidation and pharmacological treatment has not been systematically investigated in patients with type 2 diabetes (T2D). We aimed to investigate the association between pharmacological treatments and levels of urinary markers of nucleic acid oxidation in T2D patients. Vejle Diabetes Biobank cohort data was nested into nationwide registry data. Multiple logistic regression was used to associate drug usage with risk of high (above median) RNA and DNA oxidation. Data from 2664 T2D patients (64{\%} male, age range: 25-75) were included. Questionnaire-validated lipid lowering drug use was associated with low RNA oxidation (Odds ratio, OR 0.71, 95{\%} CI: [0.59-0.87]). Insulin and non-specific antidiabetic drugs were associated with low DNA oxidation (insulin: OR 0.60, 95{\%} CI [0.49-0.73]). Oral antidiabetics were associated with high DNA oxidation and RNA oxidation (OR 1.30, 95{\%} CI [1.10-1.53] and OR 1.26, 95{\%} CI [1.07-1.29]). Our findings indicate that diabetes-related drugs are associated with RNA and DNA oxidation and further studies are required to determine causality in T2D patients.",
keywords = "8-Oxo-7,8-dihydro-2-deoxyguanosine, 8-oxo-7,8-dihydroguanosine, clinical pharmacology, oxidative stress, type 2 diabetes",
author = "{Kofoed Kj{\ae}r}, Laura and Vanja Cejvanovic and Trine Henriksen and Torben Hansen and Oluf Pedersen and {Kjeldahl Christensen}, Cramer and Christian Torp-Pedersen and {Alexander Gerds}, Thomas and Ivan Brandslund and Thomas Mandrup-Poulsen and {Enghusen Poulsen}, Henrik",
year = "2019",
doi = "10.1080/10715762.2019.1622011",
language = "English",
volume = "53",
pages = "694--703",
journal = "Free Radical Research",
issn = "1071-5762",
publisher = "Informa Healthcare",
number = "6",

}

RIS

TY - JOUR

T1 - Urinary nucleic acid oxidation product levels show differential associations with pharmacological treatment in patients with type 2 diabetes

AU - Kofoed Kjær, Laura

AU - Cejvanovic, Vanja

AU - Henriksen, Trine

AU - Hansen, Torben

AU - Pedersen, Oluf

AU - Kjeldahl Christensen, Cramer

AU - Torp-Pedersen, Christian

AU - Alexander Gerds, Thomas

AU - Brandslund, Ivan

AU - Mandrup-Poulsen, Thomas

AU - Enghusen Poulsen, Henrik

PY - 2019

Y1 - 2019

N2 - The relationship between RNA and DNA oxidation and pharmacological treatment has not been systematically investigated in patients with type 2 diabetes (T2D). We aimed to investigate the association between pharmacological treatments and levels of urinary markers of nucleic acid oxidation in T2D patients. Vejle Diabetes Biobank cohort data was nested into nationwide registry data. Multiple logistic regression was used to associate drug usage with risk of high (above median) RNA and DNA oxidation. Data from 2664 T2D patients (64% male, age range: 25-75) were included. Questionnaire-validated lipid lowering drug use was associated with low RNA oxidation (Odds ratio, OR 0.71, 95% CI: [0.59-0.87]). Insulin and non-specific antidiabetic drugs were associated with low DNA oxidation (insulin: OR 0.60, 95% CI [0.49-0.73]). Oral antidiabetics were associated with high DNA oxidation and RNA oxidation (OR 1.30, 95% CI [1.10-1.53] and OR 1.26, 95% CI [1.07-1.29]). Our findings indicate that diabetes-related drugs are associated with RNA and DNA oxidation and further studies are required to determine causality in T2D patients.

AB - The relationship between RNA and DNA oxidation and pharmacological treatment has not been systematically investigated in patients with type 2 diabetes (T2D). We aimed to investigate the association between pharmacological treatments and levels of urinary markers of nucleic acid oxidation in T2D patients. Vejle Diabetes Biobank cohort data was nested into nationwide registry data. Multiple logistic regression was used to associate drug usage with risk of high (above median) RNA and DNA oxidation. Data from 2664 T2D patients (64% male, age range: 25-75) were included. Questionnaire-validated lipid lowering drug use was associated with low RNA oxidation (Odds ratio, OR 0.71, 95% CI: [0.59-0.87]). Insulin and non-specific antidiabetic drugs were associated with low DNA oxidation (insulin: OR 0.60, 95% CI [0.49-0.73]). Oral antidiabetics were associated with high DNA oxidation and RNA oxidation (OR 1.30, 95% CI [1.10-1.53] and OR 1.26, 95% CI [1.07-1.29]). Our findings indicate that diabetes-related drugs are associated with RNA and DNA oxidation and further studies are required to determine causality in T2D patients.

KW - 8-Oxo-7,8-dihydro-2-deoxyguanosine

KW - 8-oxo-7,8-dihydroguanosine

KW - clinical pharmacology

KW - oxidative stress

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85067042060&partnerID=8YFLogxK

U2 - 10.1080/10715762.2019.1622011

DO - 10.1080/10715762.2019.1622011

M3 - Journal article

VL - 53

SP - 694

EP - 703

JO - Free Radical Research

JF - Free Radical Research

SN - 1071-5762

IS - 6

ER -

ID: 57340695